Researchers also discovered GLP-1s may treat kidney disease, cancer, sleep apnea, high blood pressure and fatty liver disease
According to the Victoza website, the drug helps those with type 2 diabetes by slowing down the rate at which food leaves your stomach, regulating the livers production of sugar, and helping the pancreas produce the appropriate amount of insulin
According to FDA-approved labeling and clinical trial data, the following side effects occur most commonly: Gastrointestinal Effects: Nausea (affecting 1544% of patients, with higher rates at Wegovy doses) [3] [4] Diarrhea (reported in 830% of patients) Vomiting (524% incidence) Constipation (occurring in 324% of patients) Abdominal pain (520% of patients) These gastrointestinal symptoms typically emerge during dose escalation and often diminish with continued therapy as physiological adaptation occurs

It is not known if RYBELSUS will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people Do not use RYBELSUS if: you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) you have had a serious allergic reaction to semaglutide or any of the ingredients in RYBELSUS Before using RYBELSUS , tell your healthcare provider if you have any other medical conditions, including if you: have or have had problems with your pancreas or kidneys have a history of vision problems related to your diabetes are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation) are pregnant or plan to become pregnant